Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00281021
Status:
TERMINATED
Last Update Posted:
2018-03-29
First Post:
2006-01-23
Brief Title:
Second Line Erlotinib Tarceva Plus Digoxin in Non-Small Cell Lung Cancer
Sponsor:
University of Louisville
Organization:
University of Louisville
Organization Data
Organization:
University of Louisville
Class:
OTHER
Study ID:
62905
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Louisville
Lead Sponsor Class:
OTHER
Responsible Party:
Goetz Kloecker
Responsible Party Title:
Associate Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Louisville
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| James Graham Brown Cancer Center | OTHER |